pln-74809
Showing 1 - 5 of 5
Idiopathic Pulmonary Fibrosis Trial in Boston (PLN-74809, Placebo)
Recruiting
- Idiopathic Pulmonary Fibrosis
- PLN-74809
- Placebo
-
Boston, MassachusettsMassachusetts General Hospital
Nov 14, 2022
Idiopathic Pulmonary Fibrosis Trial in Palo Alto (PLN-74809, Knottin tracer)
Completed
- Idiopathic Pulmonary Fibrosis
- PLN-74809
- Knottin tracer
-
Palo Alto, CaliforniaStanford Medical Center
Nov 15, 2022
Idiopathic Pulmonary Fibrosis Trial in Australia, United States (PLN-74809, Placebo)
Recruiting
- Idiopathic Pulmonary Fibrosis
- PLN-74809
- Placebo
-
Redding, California
- +15 more
Oct 18, 2023
Acute Respiratory Distress Syndrome, SARS-CoV-2 Trial in United States (PLN-74809, Placebo)
Terminated
- Acute Respiratory Distress Syndrome
- SARS-CoV-2
- PLN-74809
- Placebo
-
Phoenix, Arizona
- +5 more
Oct 8, 2021
Idiopathic Pulmonary Fibrosis Trial in Worldwide (PLN-74809, Placebo)
Active, not recruiting
- Idiopathic Pulmonary Fibrosis
- PLN-74809
- Placebo
-
Phoenix, Arizona
- +38 more
Aug 17, 2022